Antiedematous effects of combination therapies with the leukotriene synthesis inhibitor BAY X 1005 in the arachidonic acid-induced mouse ear inflammation test

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 56, Issue 4, 1997, Pages 301-306

  Burchardt, E R ^a   Muller Peddinghaus R ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; INDOMETACIN; MEPYRAMINE; METHYSERGIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OTITIS; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030936421     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90574-3     Document Type: Article

References (34)

1. Fruchtmann R., Mohrs K. H., Hatzelmann A. et al. In vitro pharmacology of BAY X 1005, a new inhibitor of leukotriene synthesis. Agents Actions 1993; 38: 188-195.
2. 4. Biochem Pharmacol 1994; 48: 31-39.
3. Barnes P.J. A new approach to the treatment of asthma. N Engl J Med 1989; 321: 1517-1527.
4. Moilanen E. Prostanoids and leukotrienes in rheumatoid synovitis. Pharmacol Toxicol 1994; 75: (Suppl. II) 4-8.
5. Chang J., O'Neil-Davis L., Lamb B., Carlson R. P., Lewis A. J. The utility of arachidonic acid-treated mouse ear inflammatory model as a potential screen for lipoxygenase (LO) inhibitors. Agents Actions 1985; 16: 600.
6. Young J. M., Spires D. A., Bedord C. J., Wagner B. M., Ballaron S. J., de Young L. M. The mouse ear inflammatory response to topical arachidonic acid. J Invest Dermatol 1984; 82: 367-371.
7. Müller-Peddinghaus R., Malorny U., Kohlsdorfer C., Theisen-Popp P., Sorg C. Acute inflammation in mouse skin to study leukocyte infiltration and the influence of leukotriene synthesis inhibition. In: Müller-Peddinghaus R., ed. Leukotrienes and Vascular Phenomena of Inflammation Related to Rheumatoid Arthritis. Basel: EULAR Publishers, 1992: 73-82.
8. Young J. M., Wagner B. M., Spires D. A. Tachyphylaxis in 12-0-tetradecanoylphorbol acetate-and arachidonic acid-induced ear edema. J Invest Dermatol 1983; 80: 48-52.
9. Chang J., Carlson R. P., O'Neill-Davis L., Lamb B., Sharma R. N., Lewis A.J. Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis. Inflammation 1986; 10: 205-214.
10. Inoue H., Mori T., Koshihara Y. Sulfidopeptide-leukotrienes are major mediators of arachidonic acid-induced mouse ear edema. Prostaglandins 1988; 36: 731-740.
11. Arner E. C., Rule B. L., Rudnick M. S., Galbraith W. Arachidonic acid-induced ear edema: correlation of swelling with production of lipoxygenase (LO) products. Agents Actions 1985; 16: 600-610.
12. Opas E. E., Bonney R.J., Humes J. L. Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. J Invest Dermatol 1985; 84: 253-256.
13. Tarayre J. P., Aliaga M., Barbara M., Tisne-Versailles J. Hypotheses on a possible role of some mediators in various inflammatory reactions on mouse ear. Methods Find Exp Clin Pharmacol 1988; 10: 623-627.
14. Nagai H., Suda H., Kitagaki K., Goto S., Koda A. Anti-allergic effects of ketanserin on animal models of allergic reactions. Arch Int Pharmacodyn 1990; 307: 172-182.
15. Carlson R. P., O'Neill-Davis L., Chang J., Davis A.J. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 1985; 17: 194-204.
16. Gillard J., Ford-Hutchinson A. W., Chan C. et al. L-663,536(MK886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2yl]-2,2- dimethylpropanionic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol 1989; 67: 456-464.
17. Müller-Peddinghaus R., Kohlsdorfer C., Theisen-Popp P. et al. BAY X 1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics. J Pharmacol Exp Ther 1993; 267: 51-57.
18. Griswold D. E., Webb E., Schwartz L., Hanna N. Arachidonic acid-induced inflammation: inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002. Inflammation 1987; 11: 189-199.
19. Blackham A., Griffith R. J., Hallam C. et al. FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor. Agents Actions 1990; 30: 432-442.
20. Crummey A., Harper G. P., Boyle E. A., Mangan F. R. Inhibition of arachidonic acid-induced ear edema as a model for assessing topical anti-inflammatory compounds. Agents Actions 1987; 20: 69-76.
21. 2 receptor mediated inhibition of immediate type hypersensitivity reactions in vivo. Am Rev Respir Dis 1978; 117: 479-484.
22. 2 receptor blockade and bronchial hyperreactivity to histamine in asthma. Thorax 1981; 36: 268-271.
23. Lewis A.J., Musser J. H., Chang J., Silver P.J. 7 new approaches to bronchodilator and antiallergic drug therapy. Prog Med Chem 1985; 22: 293-359.
24. 1-passively sensitized guinea pig lungs. J Pharmacol Exp Ther 1990; 255: 664-671.
25. Chung K. F., Barnes P.J. Role of inflammatory mediators in asthma. Br Med Bull 1991; 48: 135-148.
26. Carter G. W., Young P. R, Albert D. H. et al. 5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 1991; 256: 929-937.
27. Raud J., Thorlacius J., Xie X., Lindbom L., Hedqvist P. Interactions between histamine and leukotrienes in the microcirculation. Ann N Ÿ Acad Sci 1994; 744: 191-198.
28. Provost P., Lam J. Y. T., Lacoste L., Merhi Y., Waters D. Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscl Thromb 1994; 14: 331-335.
29. Kurose I., Wolf R., Grisham M. B., Granger D. N. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am J Physiol 1995; 268: H2224-H2231.
30. Kotyuk B., Raychaudhuri A., DiPasquale G. Effect of anti-inflammatory compounds on edema formation and myeloperoxidase activity in the arachidonic acid-induced ear model in the mouse. Agents Actions 1993; 39: C46-C48.
31. Bouclier M., Luginbuhl B., Shroot B., Hemsby C. N. Arachidonic acid induced ear oedema in four strains of rats and mice: a comparative study of anti-inflammatory drugs. Agents Actions 1990; 18: 62-64.
32. Salvemini D., Misko T. P., Masferer J. L., Seibert K., Currie M. G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-7244.
33. Wikström Jansson E., Dahlen S. V. Interactions between leukotrienes and histamine in the anaphylactic contractions of guinea pig lung parenchyma. J Exp Ther 1994; 271: 615-623.
34. Gardiner P.J., Cuthbert N.J., Francis H. P. et al. Inhibition of antigen-induced contraction of guinea pig airways by a leukotriene synthesis inhibitor, BAY X 1005. Eur J Pharmacol 1994; 258: 95-102.